APTARGROUP, INC. 8-K

What Happened

• On March 16, 2026 AptarGroup (ATR) announced that President & CEO Stephan Tanda will retire as CEO effective September 1, 2026. The Board appointed Gael Touya (currently President, Aptar Pharma) as President & CEO effective that date; Mr. Touya is expected to join the Board on the Effective Date. Mr. Tanda will remain employed as a strategic advisor and continue as a Board member through December 31, 2026.

Key Details

• Touya employment terms: initial base salary $1,060,000; initial term Sept. 1, 2026–Dec. 31, 2028, auto-extends annually (no later than Dec. 31, 2034).
• Incentives and equity: 2026 post‑Effective Date target annual incentive set at 120% of base (prorated); LTI target at least 500% of base salary; incremental equity awards to be granted and prorated.
• Other compensation/benefits: Company to pay up to $50,000 of Touya’s legal fees; to contribute an amount equal to €2,506,320 (subject to update) to a U.S. nonqualified plan in lieu of French defined‑benefit plan rights; relocation to Chicago with tax gross‑up and repatriation reimbursement under certain conditions.
• Severance and change‑in‑control: termination without cause — 1.5× base salary and 1.5× incentive (or average) paid over 18 months plus benefits; death — estate receives 1/2 base salary for two years; non‑extension — one year base + target bonus; post‑change‑in‑control qualifying termination — lump sum equal to 3× salary and 3× average incentives plus 3 years of benefits. Noncompete/nonsolicit covenants apply (18–24 months).
• Tanda arrangements: remains strategic advisor through Dec. 31, 2026; 2026 target short‑term incentive 130% of base; eligible for 2026 LTI target equal to 605% of base; COBRA continuation up to 18 months and potential continued access to company medical plan thereafter.
• Retention awards: CFO Vanessa Kanu and Hedi Tlili (President – Aptar Closures) each received restricted stock units with grant‑date fair value of $1.3 million (Kanu vests after 3 years; Tlili after 2 years).

Why It Matters

• This is a planned CEO transition with material compensation commitments that could affect cash flow and equity dilution (large LTI targets, prorated equity grants, and a sizeable employer contribution replacing French DB benefits). The company also put retention equity in place for key executives (CFO and Closures president) to support continuity. Investors should note the timing of the leadership change (Sept. 1, 2026), the multi‑year employment and severance protections for the incoming CEO, and the potential governance implications of adding the new CEO to the Board.